Home > > > > Report Detail

Global Regenerative Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 16-Sep-2022
No. of pages: 133
Inquire Before Buying

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body's innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and "the vanguard of 21st century healthcare" by the U.S. Department of Health and Human Services.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Regenerative Medicine market is projected to reach US$ 115660 million by 2028 from an estimated US$ 40320 million in 2022, at a CAGR of 19.2% during 2023 and 2028.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.

The Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Regenerative Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- J & J (DePuy Synthes)

- Medtronic

- Zimmer Biomet

- Stryker

- Allergan(Acelity)

- MiMedx Group

- Organogenesis

- Fujifilm Cellular Dynamics

- Osiris Therapeutics

- Vcanbio

- CCBC

- Cytori

- Celgene

- Vericel Corporation

- Guanhao Biotech

- Mesoblast

- AMAG Pharmaceuticals (CBR)

- ViaCord

- CordLife

- Integra LifeSciences

- Nuvasive

- Cook Biotech

- Japan Tissue Engineering

Product Type Insights

Global markets are presented by Regenerative Medicine type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Regenerative Medicine are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Regenerative Medicine Segment by Type

- Cell Therapy

- Tissue Engineering

- Biomaterial

- Other

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Regenerative Medicine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Regenerative Medicine market.

Regenerative Medicine Segment by Application

- Dermatology

- Cardiovascular

- CNS

- Orthopedic

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Regenerative Medicine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Regenerative Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Regenerative Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Regenerative Medicine industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Regenerative Medicine.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Regenerative Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Regenerative Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Regenerative Medicine Market Size Estimates and Forecasts
2.2 Regenerative Medicine Market Size by Region: 2022 Versus 2028
2.2.1 Global Regenerative Medicine Revenue by Region: 2017-2022
2.2.2 Global Regenerative Medicine Revenue Forecast by Region (2023-2028)
2.2.3 Global Regenerative Medicine Revenue Market Share by Region (2017-2028)
3 Global Regenerative Medicine by Company
3.1 Global Regenerative Medicine Revenue by Company (2017-2022)
3.2 Global Regenerative Medicine Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Regenerative Medicine Companies around the World: Ranking by Revenue
3.3.2 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Regenerative Medicine Companies Headquarters & Product Type
3.4.1 Regenerative Medicine Companies Headquarters
3.4.2 Global Regenerative Medicine Companies Product & Service
3.4.3 Date of International Companies Enter into Regenerative Medicine Market
3.5 Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 J & J (DePuy Synthes)
4.1.1 J & J (DePuy Synthes) Corporation Information
4.1.2 J & J (DePuy Synthes) Description, Business Overview
4.1.3 J & J (DePuy Synthes) Regenerative Medicine Products Offered
4.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.1.5 J & J (DePuy Synthes) Regenerative Medicine Revenue by Product in 2021
4.1.6 J & J (DePuy Synthes) Regenerative Medicine Revenue by Application in 2021
4.1.7 J & J (DePuy Synthes) Regenerative Medicine Revenue by Geographic Area in 2021
4.1.8 J & J (DePuy Synthes) Recent Developments
4.2 Medtronic
4.2.1 Medtronic Corporation Information
4.2.2 Medtronic Description, Business Overview
4.2.3 Medtronic Regenerative Medicine Products Offered
4.2.4 Medtronic Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.2.5 Medtronic Regenerative Medicine Revenue by Product in 2021
4.2.6 Medtronic Regenerative Medicine Revenue by Application in 2021
4.2.7 Medtronic Regenerative Medicine Revenue by Geographic Area in 2021
4.2.8 Medtronic Recent Developments
4.3 Zimmer Biomet
4.3.1 Zimmer Biomet Corporation Information
4.3.2 Zimmer Biomet Description, Business Overview
4.3.3 Zimmer Biomet Regenerative Medicine Products Offered
4.3.4 Zimmer Biomet Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.3.5 Zimmer Biomet Regenerative Medicine Revenue by Product in 2021
4.3.6 Zimmer Biomet Regenerative Medicine Revenue by Application in 2021
4.3.7 Zimmer Biomet Regenerative Medicine Revenue by Geographic Area in 2021
4.3.8 Zimmer Biomet Recent Developments
4.4 Stryker
4.4.1 Stryker Corporation Information
4.4.2 Stryker Description, Business Overview
4.4.3 Stryker Regenerative Medicine Products Offered
4.4.4 Stryker Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.4.5 Stryker Regenerative Medicine Revenue by Product in 2021
4.4.6 Stryker Regenerative Medicine Revenue by Application in 2021
4.4.7 Stryker Regenerative Medicine Revenue by Geographic Area in 2021
4.4.8 Stryker Recent Developments
4.5 Allergan(Acelity)
4.5.1 Allergan(Acelity) Corporation Information
4.5.2 Allergan(Acelity) Description, Business Overview
4.5.3 Allergan(Acelity) Regenerative Medicine Products Offered
4.5.4 Allergan(Acelity) Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.5.5 Allergan(Acelity) Regenerative Medicine Revenue by Product in 2021
4.5.6 Allergan(Acelity) Regenerative Medicine Revenue by Application in 2021
4.5.7 Allergan(Acelity) Regenerative Medicine Revenue by Geographic Area in 2021
4.5.8 Allergan(Acelity) Recent Developments
4.6 MiMedx Group
4.6.1 MiMedx Group Corporation Information
4.6.2 MiMedx Group Description, Business Overview
4.6.3 MiMedx Group Regenerative Medicine Products Offered
4.6.4 MiMedx Group Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.6.5 MiMedx Group Regenerative Medicine Revenue by Product in 2021
4.6.6 MiMedx Group Regenerative Medicine Revenue by Application in 2021
4.6.7 MiMedx Group Regenerative Medicine Revenue by Geographic Area in 2021
4.6.8 MiMedx Group Recent Development
4.7 Organogenesis
4.7.1 Organogenesis Corporation Information
4.7.2 Organogenesis Description, Business Overview
4.7.3 Organogenesis Regenerative Medicine Products Offered
4.7.4 Organogenesis Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.7.5 Organogenesis Regenerative Medicine Revenue by Product in 2021
4.7.6 Organogenesis Regenerative Medicine Revenue by Application in 2021
4.7.7 Organogenesis Regenerative Medicine Revenue by Geographic Area in 2021
4.7.8 Organogenesis Recent Development
4.8 Fujifilm Cellular Dynamics
4.8.1 Fujifilm Cellular Dynamics Corporation Information
4.8.2 Fujifilm Cellular Dynamics Description, Business Overview
4.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Products Offered
4.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.8.5 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Product in 2021
4.8.6 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Application in 2021
4.8.7 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Geographic Area in 2021
4.8.8 Fujifilm Cellular Dynamics Recent Development
4.9 Osiris Therapeutics
4.9.1 Osiris Therapeutics Corporation Information
4.9.2 Osiris Therapeutics Description, Business Overview
4.9.3 Osiris Therapeutics Regenerative Medicine Products Offered
4.9.4 Osiris Therapeutics Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.9.5 Osiris Therapeutics Regenerative Medicine Revenue by Product in 2021
4.9.6 Osiris Therapeutics Regenerative Medicine Revenue by Application in 2021
4.9.7 Osiris Therapeutics Regenerative Medicine Revenue by Geographic Area in 2021
4.9.8 Osiris Therapeutics Recent Development
4.10 Vcanbio
4.10.1 Vcanbio Corporation Information
4.10.2 Vcanbio Description, Business Overview
4.10.3 Vcanbio Regenerative Medicine Products Offered
4.10.4 Vcanbio Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.10.5 Vcanbio Regenerative Medicine Revenue by Product in 2021
4.10.6 Vcanbio Regenerative Medicine Revenue by Application in 2021
4.10.7 Vcanbio Regenerative Medicine Revenue by Geographic Area in 2021
4.10.8 Vcanbio Recent Development
4.11 CCBC
4.11.1 CCBC Corporation Information
4.11.2 CCBC Description, Business Overview
4.11.3 CCBC Regenerative Medicine Products Offered
4.11.4 CCBC Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.11.5 CCBC Regenerative Medicine Revenue by Product in 2021
4.11.6 CCBC Regenerative Medicine Revenue by Application in 2021
4.11.7 CCBC Regenerative Medicine Revenue by Geographic Area in 2021
4.11.8 CCBC Recent Development
4.12 Cytori
4.12.1 Cytori Corporation Information
4.12.2 Cytori Description, Business Overview
4.12.3 Cytori Regenerative Medicine Products Offered
4.12.4 Cytori Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.12.5 Cytori Regenerative Medicine Revenue by Product in 2021
4.12.6 Cytori Regenerative Medicine Revenue by Application in 2021
4.12.7 Cytori Regenerative Medicine Revenue by Geographic Area in 2021
4.12.8 Cytori Recent Development
4.13 Celgene
4.13.1 Celgene Corporation Information
4.13.2 Celgene Description, Business Overview
4.13.3 Celgene Regenerative Medicine Products Offered
4.13.4 Celgene Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.13.5 Celgene Regenerative Medicine Revenue by Product in 2021
4.13.6 Celgene Regenerative Medicine Revenue by Application in 2021
4.13.7 Celgene Regenerative Medicine Revenue by Geographic Area in 2021
4.13.8 Celgene Recent Development
4.14 Vericel Corporation
4.14.1 Vericel Corporation Corporation Information
4.14.2 Vericel Corporation Description, Business Overview
4.14.3 Vericel Corporation Regenerative Medicine Products Offered
4.14.4 Vericel Corporation Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.14.5 Vericel Corporation Regenerative Medicine Revenue by Product in 2021
4.14.6 Vericel Corporation Regenerative Medicine Revenue by Application in 2021
4.14.7 Vericel Corporation Regenerative Medicine Revenue by Geographic Area in 2021
4.14.8 Vericel Corporation Recent Development
4.15 Guanhao Biotech
4.15.1 Guanhao Biotech Corporation Information
4.15.2 Guanhao Biotech Description, Business Overview
4.15.3 Guanhao Biotech Regenerative Medicine Products Offered
4.15.4 Guanhao Biotech Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.15.5 Guanhao Biotech Regenerative Medicine Revenue by Product in 2021
4.15.6 Guanhao Biotech Regenerative Medicine Revenue by Application in 2021
4.15.7 Guanhao Biotech Regenerative Medicine Revenue by Geographic Area in 2021
4.15.8 Guanhao Biotech Recent Development
4.16 Mesoblast
4.16.1 Mesoblast Corporation Information
4.16.2 Mesoblast Description, Business Overview
4.16.3 Mesoblast Regenerative Medicine Products Offered
4.16.4 Mesoblast Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.16.5 Mesoblast Regenerative Medicine Revenue by Product in 2021
4.16.6 Mesoblast Regenerative Medicine Revenue by Application in 2021
4.16.7 Mesoblast Regenerative Medicine Revenue by Geographic Area in 2021
4.16.8 Mesoblast Recent Development
4.17 AMAG Pharmaceuticals (CBR)
4.17.1 AMAG Pharmaceuticals (CBR) Corporation Information
4.17.2 AMAG Pharmaceuticals (CBR) Description, Business Overview
4.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Products Offered
4.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.17.5 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Product in 2021
4.17.6 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Application in 2021
4.17.7 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Geographic Area in 2021
4.17.8 AMAG Pharmaceuticals (CBR) Recent Development
4.18 ViaCord
4.18.1 ViaCord Corporation Information
4.18.2 ViaCord Description, Business Overview
4.18.3 ViaCord Regenerative Medicine Products Offered
4.18.4 ViaCord Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.18.5 ViaCord Regenerative Medicine Revenue by Product in 2021
4.18.6 ViaCord Regenerative Medicine Revenue by Application in 2021
4.18.7 ViaCord Regenerative Medicine Revenue by Geographic Area in 2021
4.18.8 ViaCord Recent Development
4.19 CordLife
4.19.1 CordLife Corporation Information
4.19.2 CordLife Description, Business Overview
4.19.3 CordLife Regenerative Medicine Products Offered
4.19.4 CordLife Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.19.5 CordLife Regenerative Medicine Revenue by Product in 2021
4.19.6 CordLife Regenerative Medicine Revenue by Application in 2021
4.19.7 CordLife Regenerative Medicine Revenue by Geographic Area in 2021
4.19.8 CordLife Recent Development
4.20 Integra LifeSciences
4.20.1 Integra LifeSciences Corporation Information
4.20.2 Integra LifeSciences Description, Business Overview
4.20.3 Integra LifeSciences Regenerative Medicine Products Offered
4.20.4 Integra LifeSciences Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.20.5 Integra LifeSciences Regenerative Medicine Revenue by Product in 2021
4.20.6 Integra LifeSciences Regenerative Medicine Revenue by Application in 2021
4.20.7 Integra LifeSciences Regenerative Medicine Revenue by Geographic Area in 2021
4.20.8 Integra LifeSciences Recent Development
4.21 Nuvasive
4.21.1 Nuvasive Corporation Information
4.21.2 Nuvasive Description, Business Overview
4.21.3 Nuvasive Regenerative Medicine Products Offered
4.21.4 Nuvasive Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.21.5 Nuvasive Regenerative Medicine Revenue by Product in 2021
4.21.6 Nuvasive Regenerative Medicine Revenue by Application in 2021
4.21.7 Nuvasive Regenerative Medicine Revenue by Geographic Area in 2021
4.21.8 Nuvasive Recent Development
4.22 Cook Biotech
4.22.1 Cook Biotech Corporation Information
4.22.2 Cook Biotech Description, Business Overview
4.22.3 Cook Biotech Regenerative Medicine Products Offered
4.22.4 Cook Biotech Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.22.5 Cook Biotech Regenerative Medicine Revenue by Product in 2021
4.22.6 Cook Biotech Regenerative Medicine Revenue by Application in 2021
4.22.7 Cook Biotech Regenerative Medicine Revenue by Geographic Area in 2021
4.22.8 Cook Biotech Recent Development
4.23 Japan Tissue Engineering
4.23.1 Japan Tissue Engineering Corporation Information
4.23.2 Japan Tissue Engineering Description, Business Overview
4.23.3 Japan Tissue Engineering Regenerative Medicine Products Offered
4.23.4 Japan Tissue Engineering Regenerative Medicine Revenue and Gross Margin (2017-2022)
4.23.5 Japan Tissue Engineering Regenerative Medicine Revenue by Product in 2021
4.23.6 Japan Tissue Engineering Regenerative Medicine Revenue by Application in 2021
4.23.7 Japan Tissue Engineering Regenerative Medicine Revenue by Geographic Area in 2021
4.23.8 Japan Tissue Engineering Recent Development
5 Breakdown Data by Type
5.1 Global Regenerative Medicine Revenue by Type (2017-2022)
5.2 Global Regenerative Medicine Revenue Forecast by Type (2023-2028)
5.3 Regenerative Medicine Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Regenerative Medicine Revenue by Application (2017-2022)
6.2 Global Regenerative Medicine Revenue Forecast by Application (2023-2028)
6.3 Regenerative Medicine Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Regenerative Medicine Market Size YoY Growth 2017-2028
7.2 North America Regenerative Medicine Market Facts & Figures by Country (2017-2028)
7.3 North America Regenerative Medicine Revenue by Type (2017-2022)
7.4 North America Regenerative Medicine Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Regenerative Medicine Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Regenerative Medicine Revenue by Type (2017-2022)
8.4 Asia-Pacific Regenerative Medicine Revenue by Application (2017-2022)
9 Europe
9.1 Europe Regenerative Medicine Market Size YoY Growth 2017-2028
9.2 Europe Regenerative Medicine Market Facts & Figures by Country (2017-2028)
9.3 Europe Regenerative Medicine Revenue by Type (2017-2022)
9.4 Europe Regenerative Medicine Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Regenerative Medicine Market Size YoY Growth 2017-2028
10.2 Latin America Regenerative Medicine Market Facts & Figures by Country (2017-2028)
10.3 Latin America Regenerative Medicine Revenue by Type (2017-2022)
10.4 Latin America Regenerative Medicine Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Regenerative Medicine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Regenerative Medicine Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Regenerative Medicine Revenue by Type (2017-2022)
11.4 Middle East and Africa Regenerative Medicine Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Regenerative Medicine Supply Chain Analysis
12.2 Regenerative Medicine Key Raw Materials and Upstream Suppliers
12.3 Regenerative Medicine Clients Analysis
12.4 Regenerative Medicine Sales Channel and Sales Model Analysis
12.4.1 Regenerative Medicine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Regenerative Medicine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Regenerative Medicine Distributors
13 Market Dynamics
13.1 Regenerative Medicine Industry Trends
13.2 Regenerative Medicine Market Drivers
13.3 Regenerative Medicine Market Challenges
13.4 Regenerative Medicine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Cell Therapy
Table 3. Major Companies of Tissue Engineering
Table 4. Major Companies of Biomaterial
Table 5. Major Companies of Other
Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Regenerative Medicine Market Size by Region (US$ Million): 2022 VS 2028
Table 8. Global Regenerative Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Regenerative Medicine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Regenerative Medicine Revenue by Company (2017-2022) & (US$ Million)
Table 11. Regenerative Medicine Revenue Share by Company (2017-2022)
Table 12. Ranking of Global Top Regenerative Medicine Players by Revenue (US$ Million) in 2021
Table 13. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 14. Global Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021)
Table 15. Global Regenerative Medicine Companies Headquarters
Table 16. Global Regenerative Medicine Companies Product & Service
Table 17. Date of International Companies Enter into Regenerative Medicine Market
Table 18. Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
Table 19. J & J (DePuy Synthes) Corporation Information
Table 20. J & J (DePuy Synthes) Description and Business Overview
Table 21. J & J (DePuy Synthes) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 22. J & J (DePuy Synthes) Regenerative Medicine Product
Table 23. J & J (DePuy Synthes) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 24. J & J (DePuy Synthes) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 25. J & J (DePuy Synthes) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 26. J & J (DePuy Synthes) Recent Development
Table 27. Medtronic Corporation Information
Table 28. Medtronic Description and Business Overview
Table 29. Medtronic Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 30. Medtronic Regenerative Medicine Product
Table 31. Medtronic Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 32. Medtronic Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 33. Medtronic Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 34. Medtronic Recent Development
Table 35. Zimmer Biomet Corporation Information
Table 36. Zimmer Biomet Description and Business Overview
Table 37. Zimmer Biomet Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 38. Zimmer Biomet Regenerative Medicine Product
Table 39. Zimmer Biomet Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 40. Zimmer Biomet Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 41. Zimmer Biomet Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 42. Zimmer Biomet Recent Development
Table 43. Stryker Corporation Information
Table 44. Stryker Description and Business Overview
Table 45. Stryker Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 46. Stryker Regenerative Medicine Product
Table 47. Stryker Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 48. Stryker Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 49. Stryker Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 50. Stryker Recent Development
Table 51. Allergan(Acelity) Corporation Information
Table 52. Allergan(Acelity) Description and Business Overview
Table 53. Allergan(Acelity) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 54. Allergan(Acelity) Regenerative Medicine Product
Table 55. Allergan(Acelity) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 56. Allergan(Acelity) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 57. Allergan(Acelity) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 58. Allergan(Acelity) Recent Development
Table 59. MiMedx Group Corporation Information
Table 60. MiMedx Group Description and Business Overview
Table 61. MiMedx Group Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 62. MiMedx Group Regenerative Medicine Product
Table 63. MiMedx Group Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 64. MiMedx Group Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 65. MiMedx Group Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 66. Organogenesis Corporation Information
Table 67. Organogenesis Description and Business Overview
Table 68. Organogenesis Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 69. Organogenesis Regenerative Medicine Product
Table 70. Organogenesis Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 71. Organogenesis Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 72. Organogenesis Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 73. Fujifilm Cellular Dynamics Corporation Information
Table 74. Fujifilm Cellular Dynamics Description and Business Overview
Table 75. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 76. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 77. Fujifilm Cellular Dynamics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 78. Fujifilm Cellular Dynamics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 79. Fujifilm Cellular Dynamics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 80. Osiris Therapeutics Corporation Information
Table 81. Osiris Therapeutics Description and Business Overview
Table 82. Osiris Therapeutics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 83. Osiris Therapeutics Regenerative Medicine Product
Table 84. Osiris Therapeutics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 85. Osiris Therapeutics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 86. Osiris Therapeutics Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 87. Vcanbio Corporation Information
Table 88. Vcanbio Description and Business Overview
Table 89. Vcanbio Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 90. Vcanbio Regenerative Medicine Product
Table 91. Vcanbio Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 92. Vcanbio Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 93. Vcanbio Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 94. CCBC Corporation Information
Table 95. CCBC Description and Business Overview
Table 96. CCBC Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 97. CCBC Regenerative Medicine Product
Table 98. CCBC Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 99. CCBC Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 100. CCBC Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 101. Cytori Corporation Information
Table 102. Cytori Description and Business Overview
Table 103. Cytori Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 104. Cytori Regenerative Medicine Product
Table 105. Cytori Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 106. Cytori Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 107. Cytori Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 108. Celgene Corporation Information
Table 109. Celgene Description and Business Overview
Table 110. Celgene Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 111. Celgene Regenerative Medicine Product
Table 112. Celgene Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 113. Celgene Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 114. Celgene Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 115. Vericel Corporation Corporation Information
Table 116. Vericel Corporation Description and Business Overview
Table 117. Vericel Corporation Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 118. Vericel Corporation Regenerative Medicine Product
Table 119. Vericel Corporation Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 120. Vericel Corporation Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 121. Vericel Corporation Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 122. Guanhao Biotech Corporation Information
Table 123. Guanhao Biotech Description and Business Overview
Table 124. Guanhao Biotech Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 125. Guanhao Biotech Regenerative Medicine Product
Table 126. Guanhao Biotech Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 127. Guanhao Biotech Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 128. Guanhao Biotech Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 129. Mesoblast Corporation Information
Table 130. Mesoblast Description and Business Overview
Table 131. Mesoblast Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 132. Mesoblast Regenerative Medicine Product
Table 133. Mesoblast Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 134. Mesoblast Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 135. Mesoblast Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 136. AMAG Pharmaceuticals (CBR) Corporation Information
Table 137. AMAG Pharmaceuticals (CBR) Description and Business Overview
Table 138. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 139. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 140. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 141. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 142. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 143. ViaCord Corporation Information
Table 144. ViaCord Description and Business Overview
Table 145. ViaCord Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 146. ViaCord Regenerative Medicine Product
Table 147. ViaCord Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 148. ViaCord Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 149. ViaCord Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 150. CordLife Corporation Information
Table 151. CordLife Description and Business Overview
Table 152. CordLife Regenerative Medicine Revenue (US$ Million) and Gross Margin (2017-2022)
Table 153. CordLife Regenerative Medicine Product
Table 154. CordLife Regenerative Medicine Revenue Proportion of Regenerative Medicine by Product in 2021
Table 155. CordLife Regenerative Medicine Revenue Proportion of Regenerative Medicine by Application in 2021
Table 156. CordLife Regenerative Medicine Revenue Proportion of Regenerative Medicine by Geographic Area in 2021
Table 157. Integra LifeSciences Corporation Information
Table 158. Integra LifeSciences Description and Business Overview
Table 159. Inte
  • Global Tissue Engineered Skin Substitutes Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
  • Global Tissue Engineering Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
  • Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150
    According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
  • Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
  • Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
  • Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96
    The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
  • Global Tissue Engineering and Regeneration Market Research Report 2023
    Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......
  • Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Regenerative Medicine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950
    Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs